One of the most striking features in autosomal dominant polycystic kidney disease (ADPKD) is the difference at onset age of end-stage renal disease (ESRD). Modifier genes may play a role in this phenotypic variability. The mutated nitric oxide synthase 3 gene (NOS3), have a modifier effect on the severity of ADPKD by impairment of NOS3 activity and decreasing of renal vascular nitric oxide production and, subsequently, reduced kidney function. In order to test this hypothesis, we investigated the relationship between Glu298Asp polymorphism in exon 7 of this gene and ESRD in ADPKD patients refered from Shahid Labbafi Nedjad Hospital in Tehran. The polymorphism was examined by PCR, followed by RFLP (with MboI) in three groups of ADPKD with ESRD; ADPKD without ESRD patients and normal individual as the cases, case-controls and controls, respectively. The frequencies of GG, GT, and TT genotypes in cases were 66.7%, 33.3% and 0%, in case-controls were 78.6%, 19%, 2.4%, and in controls were 64.3%, 35.7% and 0%, respectively. Our findings revealed that there was no significant difference in the genotype frequency of NOS3 gene in ADPKD patients (p=0.311).The age of onset of ESRD in ADPKD patients, harbouring the T allele of this polymorphism, was two years lower than G/G patients, but this difference was not significant (p =0.641). In conclusion, our results suggest that there is no evidence of relationship between Glu298Asp polymorphism and onset age of ESRD in Iranian ADPKD patients.
utosomal dominant polycystic kidney disease (ADPKD) is the most prevalent, potentially lethal, inherited kidney disease that its treatment is limited to reducing symptoms and mortality (1) This variability is observed among families, family members and even dizygotic twins (7) (8) gene (16) (17) . The same association was recently reported in patients with ESRD due to polycystic kidney disease (18) . Therefore, the purpose of the present study was to investigate the Glu298Asp polymorphism in Iranian ESRD patients suffering from ADPKD.
Materials and Methods
The ADPKD patients were selected from the 
Results
There is no statistically significant difference between sex and medium age in studied population (Fig. 2, 3 ). although there was no statistically significant difference between them (p=0.641) (Fig. 4) . No significant differences were found in individuals due to creatinine level (p=0.563) (Fig. 5) . In case group out of 14 individuals, carrier, of T allele 12 had abnormal creatinine. Twenty five case individuals and 17 case-control individuals, had wild type G allele and abnormal creatinine (Fig. 6 ).
Fig 5.
Comparison of creatinine between individuals, who were T allele carrier (mutated) and individuals, who had wild type G allele in three groups.
Fig 7.
Comparison of blood pressure between individuals, who were T allele carrier (mutated) and individuals, who had wild type G allele in three groups. had high blood pressure. No significant differences were found in individuals due to blood pressure (p=0.568) (Fig. 7) . Eight individuals from case group and nine individuals from case-control group,had T allele (mutated) and high blood pressure (Fig. 8) .
In this study, relationship between Although in many studies it has been referred to the fact that the T allele of this gene polymorphism results in the production of deficient protein and the reduction of its enzymatic activity which can be a risky allele for ESRD (12, 17, (26) (27) , other studies did not prove the significant differences between Glu298 and 298Asp functions (28) (29) . Thus there is still discrepancy over the fact that whether T allele plays a modifier role in eNOS activity and the decrease of the ESRD age in ADPKD patients. 
Conclusion
Glu298Asp polymorphysim of NOS3 gene was not related to decreasing ESRD age in ADPKD patients in this population. Also T allele in position 894 of this gene dose not seem to be a risk factor for progression of ADPKD.
